Your browser doesn't support javascript.
loading
Re-evaluation of rituximab therapy for idiopathic Castleman disease: Retrospective study from single-center experience.
Ide, Makoto; Ohnishi, Hiroaki; Fukumoto, Tetsuya; Ohno, Hirofumi; Yokoyama, Tomoko.
Afiliação
  • Ide M; Department of Hematology, Takamatsu Red Cross Hospital, Takamatsu, Japan.
  • Ohnishi H; Department of Hematology, Takamatsu Red Cross Hospital, Takamatsu, Japan.
  • Fukumoto T; Department of Hematology, Takamatsu Red Cross Hospital, Takamatsu, Japan.
  • Ohno H; Department of Hematology, Takamatsu Red Cross Hospital, Takamatsu, Japan.
  • Yokoyama T; Department of Nephrology, Takamatsu Red Cross Hospital, Takamatsu, Japan.
Eur J Haematol ; 108(4): 354-355, 2022 04.
Article em En | MEDLINE | ID: mdl-34958695
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Hiperplasia do Linfonodo Gigante Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Hiperplasia do Linfonodo Gigante Idioma: En Ano de publicação: 2022 Tipo de documento: Article